124 related articles for article (PubMed ID: 34238798)
21. Role of positron emission tomography in thyroid and neuroendocrine tumors.
Treglia G; Kroiss AS; Piccardo A; Lococo F; Santhanam P; Imperiale A
Minerva Endocrinol; 2018 Sep; 43(3):341-355. PubMed ID: 28949122
[TBL] [Abstract][Full Text] [Related]
22. Volumetric parameters from [
Langen Stokmo H; Aly M; Bowitz Lothe IM; Borja AJ; Mehdizadeh Seraj S; Ghorpade R; Miao X; Hjortland GO; Malinen E; Sorbye H; Werner TJ; Alavi A; Revheim ME
J Neuroendocrinol; 2022 Jul; 34(7):e13170. PubMed ID: 35729738
[TBL] [Abstract][Full Text] [Related]
23. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
24. Poorly Differentiated Neuroendocrine Tumor With 18F-Fluciclovine Uptake in a Patient With Metastatic Castrate-Resistant Prostate Cancer.
Abiodun-Ojo OA; Akintayo AA; Harik LR; Bilen M; Halkar RK
Clin Nucl Med; 2021 May; 46(5):e282-e285. PubMed ID: 33208627
[TBL] [Abstract][Full Text] [Related]
25. Small Bowel Carcinoid: The "Dancing Bowel Sign" on 18F-FDOPA PET/CT.
Helali M; Heimburger C; Rohr S; Goichot B; Imperiale A
Clin Nucl Med; 2016 Dec; 41(12):944-945. PubMed ID: 27749424
[TBL] [Abstract][Full Text] [Related]
26. Pituitary metastases from neuroendocrine neoplasms: case report and narrative review.
Ragni A; Nervo A; Papotti M; Prencipe N; Retta F; Rosso D; Cacciani M; Zamboni G; Zenga F; Uccella S; Cassoni P; Gallo M; Piovesan A; Arvat E
Pituitary; 2021 Oct; 24(5):828-837. PubMed ID: 34342837
[TBL] [Abstract][Full Text] [Related]
27. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging.
Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L
Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
30. Poorly Differentiated Neuroendocrine Carcinoma of the Parotid Gland and Moderately Differentiated Hepatic Metastases: A Discordant Histopathology Clarified by Dual-Tracer PET/CT.
Sharma P; Basu S
J Nucl Med Technol; 2021 Mar; 49(1):86-88. PubMed ID: 33020231
[TBL] [Abstract][Full Text] [Related]
31. Potential for Increasing Uptake of Radiolabeled
Pollard JH; Menda Y; Zamba KD; Madsen M; O'Dorisio MS; O'Dorisio T; Bushnell D
Cancer Biother Radiopharm; 2021 Oct; 36(8):632-641. PubMed ID: 34252288
[No Abstract] [Full Text] [Related]
32. 68Ga-DOTATATE Uptake in an Intraosseous Hemangioma, as a Potential Cause of False-Positive PET/CT Finding, Simulating Tumoral Involvement.
Saidi B; Fallahi B; Manafi-Farid R; Fard-Esfahani A; Eftekhari M
Clin Nucl Med; 2022 Mar; 47(3):e274-e275. PubMed ID: 35025790
[TBL] [Abstract][Full Text] [Related]
33. 6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
Jager PL; Chirakal R; Marriott CJ; Brouwers AH; Koopmans KP; Gulenchyn KY
J Nucl Med; 2008 Apr; 49(4):573-86. PubMed ID: 18344441
[TBL] [Abstract][Full Text] [Related]
34. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis.
Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L
Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928
[TBL] [Abstract][Full Text] [Related]
35. [
Rinzivillo M; Prosperi D; Mazzuca F; Magi L; Iannicelli E; Pilozzi E; Franchi G; Laghi A; Annibale B; Signore A; Panzuto F
J Endocrinol Invest; 2021 Apr; 44(4):811-818. PubMed ID: 32767279
[TBL] [Abstract][Full Text] [Related]
36. Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN).
Kong G; Grozinsky-Glasberg S; Hofman MS; Akhurst T; Meirovitz A; Maimon O; Krausz Y; Godefroy J; Michael M; Gross DJ; Hicks RJ
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):718-727. PubMed ID: 30343432
[TBL] [Abstract][Full Text] [Related]
37. False-Positive Uptake in Splenic Hemangioma on 68 Ga-DOTATATE PET/CT.
Zhu B; Yoon E; Mahajan S; Kranz AO
Clin Nucl Med; 2023 Jun; 48(6):518-519. PubMed ID: 37075248
[TBL] [Abstract][Full Text] [Related]
38. Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.
Malczewska A; Witkowska M; Wójcik-Giertuga M; Kuśnierz K; Bocian A; Walter A; Rydel M; Robek A; Pierzchała S; Malczewska M; Leś-Zielińska I; Czyżewski D; Ziora D; Pilch-Kowalczyk J; Zajęcki W; Kos-Kudła B
Neuroendocrinology; 2021; 111(4):304-319. PubMed ID: 32335553
[TBL] [Abstract][Full Text] [Related]
39. Current status of PET imaging of neuroendocrine tumours ([18F]FDOPA, [68Ga]tracers, [11C]/[18F]-HTP).
Ambrosini V; Morigi JJ; Nanni C; Castellucci P; Fanti S
Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):58-69. PubMed ID: 25677589
[TBL] [Abstract][Full Text] [Related]
40. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
